NurExone Biologic Inc. (TSXV:NRX)
Canada · Delayed Price · Currency is CAD 0.6500
+0.0100 (1.56%)
At close: Jan 9, 2026
NurExone Biologic Market Cap
NurExone Biologic has a market cap or net worth of CAD 58.94 million as of January 9, 2026. Its market cap has increased by 7.98% in one year.
Market Cap
58.94M
Enterprise Value
57.68M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.65
Market Cap Chart
Since June 23, 2022, NurExone Biologic's market cap has increased from 33.48M to 58.94M, an increase of 76.04%. That is a compound annual growth rate of 17.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 58.94M | -1.52% |
| Dec 31, 2025 | 59.85M | 36.16% |
| Dec 31, 2024 | 43.95M | 208.80% |
| Dec 28, 2023 | 14.23M | -14.84% |
| Dec 22, 2022 | 16.71M | -50.08% |
| Jun 23, 2022 | 33.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.74B |
| Green Thumb Industries | 2.64B |
| dentalcorp Holdings | 2.19B |
| Extendicare | 2.08B |
| Trulieve Cannabis | 2.04B |
| Sienna Senior Living | 2.01B |
| Cronos Group | 1.41B |
| WELL Health Technologies | 1.04B |